DTX-P7
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


DTX-P7
Description :
DTX-P7 is a peptide-drug conjugate. DTX-P7, composed of Docetaxel (DTX, HY-B0011) and a heptapeptide (P7), induces unfolded protein response and subsequent apoptosis by degrading Hsp90[1].UNSPSC :
12352209Target :
Apoptosis; Eukaryotic Initiation Factor (eIF) ; HSP; Peptide-Drug Conjugates (PDCs) ; PERKType :
PeptidesRelated Pathways :
Antibody-drug Conjugate/ADC Related; Apoptosis; Cell Cycle/DNA Damage; Metabolic Enzyme/ProteaseApplications :
Cancer-Kinase/proteaseField of Research :
CancerAssay Protocol :
https://www.medchemexpress.com/dtx-p7.htmlSmiles :
O=C(OC(C)(C)C)N[C@H]([C@@H](OC(CCC(N[C@@H](CC(C)C)C(N1[C@H](C(N[C@H](C(N[C@@H]([C@H](O)C)C(N2CCC[C@H]2C(N[C@@H](CC(C)C)C(N3CCC[C@H]3C(O)=O)=O)=O)=O)=O)CC(C)C)=O)CCC1)=O)=O)=O)C(O[C@@H]4C(C)=C([C@@H](O)C([C@@]5(C)[C@]([C@@](CO6)(OC(C)=O)[C@@]6([H])C[C@@H]5O)([H])[C@@H]7OC(C8=CC=CC=C8)=O)=O)C(C)(C)[C@@]7(O)C4)=O)C9=CC=CC=C9Molecular Formula :
C84H118N8O25Molecular Weight :
1639.87References & Citations :
[1]Yao Jiang, et al. DTX-P7, a peptide-drug conjugate, is highly effective for non-small cell lung cancer. J Hematol Oncol. 2022 Jun 3;15 (1) :73.Shipping Conditions :
Room temperatureScientific Category :
PeptidesClinical Information :
No Development Reported

